**To the Editor:** Group A rotaviruses (RVAs) are a leading cause of acute gastroenteritis-associated deaths among children \<5 years of age in developing countries ([@R1]). The genome of RVA consists of 11 double-stranded RNA segments that code for 11 or 12 viral proteins (VP1--VP4, VP6, VP7, nonstructural protein 1 \[NSP1\]--NSP5/6) ([@R2]). In 2008, the Rotavirus Classification Working Group established a system of extended classification that was based on the sequences of all 11 gene segments and used the notations Gx-P\[x\]-Ix-Rx-Cx-Mx-Ax-Nx-Tx-Ex-Hx for the genes VP7, VP4, VP6, VP1--VP3, NSP1--NSP5, respectively ([@R3]). Similar to other RNA viruses, RVAs show high genomic diversity, which is generated primarily through point mutations, reassortment, rearrangement, and recombination events.

In 2006 and 2008, two live-attenuated vaccines, RotaTeq (Merck, Whitehouse Station, NJ, USA) and Rotarix (GlaxoSmithKline, Rixensart, Belgium), respectively, were introduced in the United States ([@R4]). RotaTeq is a pentavalent human bovine reassortant vaccine that contains 4 G types (G1, G2, G3, and G4; VP7 gene) plus the P\[8\] VP4 type on a bovine WC3 (G6P\[5\]) backbone ([@R5]). In 2012, Bucardo et al. reported finding a vaccine-derived nonstructural protein 2 (NSP2) gene in 2 wild-type RVA strains with a G1P\[8\] genogroup 1 backbone ([@R6]). Each of these strains had been found during routine surveillance in Nicaragua, where RotaTeq was introduced in 2006, suggesting reassortment of the vaccine strain with circulating wild-type strains. The authors also examined alignments of the NSP2 gene and found no differences at functional domains between the vaccine-derived NSP2 and the circulating wild-type NSP2 ([@R6]). This finding could explain why a vaccine-derived NSP2 reassortant was viable.

During the 2010--11 surveillance season, the New Vaccine Surveillance Network identified an RVA strain, RVA/human-wt/USA/2011729115/2011/G2P\[4\] (2011729115), which also contained a vaccine-derived NSP2 gene. This specimen was obtained from a 4-year-old child through routine active surveillance in the emergency department at Texas Children's Hospital (Houston, TX, USA). RVA double-stranded RNA was extracted from a fecal sample from the child by using Trizol reagent (Life Technologies, Grand Island, NY, USA). The sequencing templates were prepared by using sequence-independent whole-genome reverse transcription PCR amplification ([@R7]) with slight modifications. PCR amplicons were sequenced by the Illumina Miseq 150 paired-end method at the Genomics Laboratory, Hudson Alpha Institute for Biotechnology (Huntsville, AL, USA). Illumina sequence reads were analyzed by using CLC Genomics Workbench 6.0. (<http://www.clcbio.com/products/clc-genomics-workbench/>). A combination of de novo assembly followed by mapping to a G2P\[4\] reference strain was used to obtain the full-length genome of strain 2011729115. The sequences were submitted to GenBank under accession nos. KR701624--KR701634. Genotype assignment for each gene was performed by using a combination of BLAST (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) and RotaC 2.0 (<http://rotac.regatools.be/>). For each gene, multiple alignments were made by using the MUSCLE algorithm implemented in MEGA 5.1 ([@R8]). Maximum-likelihood trees were constructed for each gene in PhyML 3.0 (<http://www.atgc-montpellier.fr/phyml/>) by using the optimal model for each alignment as identified by jModeltest 2 (TrN+I) and approximate-likelihood ratio test (aLRT) statistics computed for branch support ([@R9],[@R10]).

The full genotype constellation for strain 2011729115 is G2-P\[4\]-I2-R2-C2-M2-A2-N2-T2-E2-H2, which is a DS-1 like constellation. The G2P\[4\] strains from the 2010--11 season shared 97.6%--100% nt identity for the NSP2 gene, except for strain 2011729115, which exhibited only 86.8%--87.3% nt identity with the other circulating G2P\[4\] strains. BLAST analysis of sequences deposited in GenBank indicated that the 2011729115 NSP2 gene was 100% identical to published RotaTeq NSP2 gene sequences and clustered with the 5 RotaTeq NSP2 sequences in phylogenetic analysis ([Figure](#F1){ref-type="fig"}). The NSP2 protein functions as a single-stranded RNA binding protein, nucleic acid helix destabilizer, nucleoside triphosphatase (NTP), nucleoside diphosphate kinase (NDP), and RNA triphosphatase (RTPase) ([@R2]). No amino acid differences in the RNA binding and NDP/NTP/RTPase domains were found between the NSP2 gene from strain 2011729115 and the G2P\[4\] strains (data not shown), suggesting that this vaccine-derived NSP2 protein can function like the wild-type version.
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In conclusion, we identified an NSP2 gene RotaTeq reassortant in an RVA with a DS-1 like genotype. Although the child from whom the NSP2 reassortment specimen was obtained had been vaccinated with a complete regimen of 3 doses of RotaTeq in 2007, no other RotaTeq genes could be detected in the fecal sample. This finding could suggest a reassortment event and infection independent of the vaccination in 2007, although precisely where this reassortment event took place is difficult to ascertain. The existence of a viable NSP2 wild-type reassortant was also proposed by Bucardo et al. ([@R6]). Whether the RotaTeq NSP2 gene provides any fitness advantage to the virus during infection of vaccinated children also is unclear; during the 2010--11 season, other cases of G2P\[4\]-associated gastroenteritis in vaccinated children, in which the RotaTeq NSP2 gene was lacking, were reported. Our finding of strain RVA/human-wt/USA/2011729115/2011/G2P\[4\], a wild-type RVA with a vaccine-derived NSP2 gene, in a child with acute gastroenteritis in the United States highlights the need for continued rotavirus surveillance, domestically and internationally, after vaccine introduction.
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